BBIO Cash & Equivalents
Bridgebio Pharma Inc · Cash & Equivalents
BBIO Cash & Equivalents
Latest reported$570.12Mperiod ending
BBIO FY Cash & Equivalents ($92.00M → $570.12M)
Annual Cash & Equivalents
High-resolution chart · PNG
BBIO cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 570,119,000 | |
| 681,101,000 | |
| 375,935,000 | |
| 376,689,000 | |
| 393,772,000 | |
| 356,082,000 | |
| 363,773,000 | |
| 436,086,000 | |
| 91,995,000 |